Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction

OM Thompson, SAA Beresford, EA Kirk, MP Bronner… - …, 2010 - Wiley Online Library
Persons diagnosed with Barrett's esophagus (BE) are at increased risk of developing
esophageal adenocarcinoma (EA). Obesity is a major risk factor for both BE and EA. The …

Associations of serum adiponectin and leptin with Barrett's esophagus

KB Greer, GW Falk, B Bednarchik, L Li… - Clinical Gastroenterology …, 2015 - Elsevier
Background & Aims Central adiposity is a risk factor for Barrett's esophagus (BE). Serum
levels of adiponectin and leptin are deregulated in obese states and are implicated as …

Leptin and the risk of Barrett's oesophagus

BJ Kendall, GA Macdonald, NK Hayward, JB Prins… - Gut, 2008 - gut.bmj.com
Background: Obesity is associated with increased risks of Barrett's oesophagus and
oesophageal adenocarcinoma. Alterations in serum leptin and adiponectin, obesity-related …

Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma

C Duggan, L Onstad, S Hardikar, PL Blount… - Clinical …, 2013 - Elsevier
Background & Aims Individuals with Barrett's esophagus (BE) have an increased risk of
developing esophageal adenocarcinoma (EA). Obesity contributes to the development of BE …

Adiponectin may modify the risk of Barrett's esophagus in patients with gastroesophageal reflux disease

LM Almers, JE Graham, PJ Havel, DA Corley - Clinical Gastroenterology …, 2015 - Elsevier
Background & Aims Abdominal obesity and increasing body mass index are risk factors for
esophageal adenocarcinoma and its main precursor, Barrett's esophagus; however, there …

Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison …

A Mokrowiecka, P Daniel, A Jasinska… - Hepato …, 2012 - europepmc.org
Results The serum concentration of adiponectin was significantly lower in BE compared to
those in GERD and to controls (p< 0.001). Levels of leptin was slightly higher in BE than in …

Association of serum levels of adipokines and insulin with risk of Barrett's esophagus: a systematic review and meta-analysis

AK Chandar, S Devanna, C Lu, S Singh, K Greer… - Clinical …, 2015 - Elsevier
Background & Aims Metabolically active visceral fat may be associated with esophageal
inflammation, metaplasia, and neoplasia. We performed a meta-analysis to evaluate the …

A pilot study of the association of low plasma adiponectin and Barrett's esophagus

JH Rubenstein, A Dahlkemper, JY Kao… - Official journal of the …, 2008 - journals.lww.com
METHODS We conducted a case–control study in cases of BE compared with controls
without BE; most controls had GERD. Odds ratios (OR), corresponding to associations with …

Visceral obesity and the risk of Barrett's esophagus

T Akiyama, M Yoneda, S Maeda, A Nakajima… - Digestion, 2011 - karger.com
It still remains controversial whether simple obesity, as measured by the body mass index
(BMI), is an independent risk factor for Barrett's esophagus (BE). Recent studies have shown …

[PDF][PDF] Adiponectin and leptin receptors expression in Barrett's esophagus and normal squamous epithelium in relation to central obesity status

A Mokrowiecka, M Sokolowska, E Luczak… - J Physiol …, 2013 - jpp.krakow.pl
Esophageal adenocarcinoma incidence is rapidly increasing which may be due to the
growing incidence of Barrett's esophagus (BE) and obesity. The mechanisms linking obesity …